Serum GDF-15 level (pg/ml) | Test value | P-value | Sig. | |||
---|---|---|---|---|---|---|
Median (IQR) | Range | |||||
PICU admission | No | 453.89 (202.2–594.32) | 47.47–2335.44 | − 6.202 | < 0.001 | HS |
Yes | 1296.02 (991.14–1871.58) | 346.5–2940.2 | ||||
Duration of admission | Duration ≤ 10 days | 521.26 (223.72–688.5) | 47.47–2311.8 | − 2.227‡ | 0.023 | S |
Duration > 10 days | 802.6 (401.52–1390.82) | 119.11 –2940.2 | ||||
Comorbidities | No | 521.26 (235.92–944.32) | 47.47–2522.24 | − 3.412‡ | 0.001 | HS |
Yes | 1035.92 (675.34–1443.5) | 176.6–2940.2 | ||||
Clinical severity | Mild to Moderate | 346.5 (202.2–537.82) | 47.47– 854.1 | 49.047‡‡ | < 0.001 | HS |
Severe | 999.76 (786.12–1218.46) | 119.11–2335.44 | ||||
Critically ill | 1871.58 (1390.82–2319.22) | 1038.84–2940.2 | ||||
Outcome | Non-survivors (N = 8) | 1555.95 (1256.14–2420.73) | 1038.84–2940.2 | − 3.691‡ | < 0.001 | HS |
Survivors (N = 64) | 570.59 (323.6–999.76) | 47.47–2402.6 |